Controversial Utah Bill Threatens FDA’s Authority Over Stem Cell Therapies
In a concerning development for the field of stem cell research and therapy, the International Society for Cell & Gene Therapy (ISCT) has voiced its opposition to a proposed bill in Utah that could undermine the U.S. Food and Drug Administration’s (FDA) ability to regulate stem cell products and protect patient safety. The bill, known as the “Right to […]
Innovative Approach to Improve Quality of Life Post-Stem Cell Transplantation
A recent study published in the June 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights a promising new approach for alleviating anxiety and enhancing the quality of life in patients undergoing hematopoietic stem cell transplantation (HSCT). This pilot study, conducted by researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, explored […]
REPROCELL USA Secures Funding from Maryland Stem Cell Research Fund (MSCRF)
REPROCELL USA, a leader in the production of clinically relevant human induced pluripotent stem cells (hiPSCs), has announced the receipt of funding from the Maryland Stem Cell Research Fund (MSCRF) for both of its proposals submitted in the January 2024 grant cycle. These grants will significantly enhance the company’s capabilities in cell therapy and therapeutic […]
Accelerating Heart Disease Research: Allen Institute’s New Disease-Specific Cell Lines
On June 4, 2024, the Allen Institute for Cell Science announced the launch of its first disease-specific cell line collections, marking a significant milestone in genetic heart disease research. This innovative set of tools, specifically designed to advance the study of hypertrophic cardiomyopathy (HCM) and other muscle disorders, represents a groundbreaking step in the quest […]
Unleashing the Power of Stem Cells: STEMREGEN® Launches Three Innovative Supplements at Biohacking Conference
In a groundbreaking announcement at the Biohacking Conference in Dallas, Texas, STEMREGEN® unveiled three new stem cell-boosting supplements designed to enhance the body’s natural repair system. As the pioneer in stem cell science-backed supplements, STEMREGEN® continues to lead the way with innovative products that support healthy aging and athletic recovery. STEMREGEN® Release: Enhancing Innate Repair […]
REPROCELL USA Launches Advanced GMP Facility for Stem Cell Manufacturing
REPROCELL USA has marked a significant milestone with the inauguration of its state-of-the-art GMP manufacturing facility dedicated to producing high-quality stem cells. This facility, located in Beltsville, Maryland, was officially opened on May 15, 2024, by Mr. Kevin Anderson, Secretary of the Department of Commerce, State of Maryland. The new facility is designed to manufacture […]
New York Blood Center Expands GMP Cell & Gene Therapy Manufacturing in Louisville
New York Blood Center Enterprises (NYBCe) has announced the grand opening of its new GMP facility in Louisville, Kentucky. This state-of-the-art site, part of Comprehensive Cell Solutions (CCS), enhances cell and gene therapy manufacturing capabilities, offering end-to-end services from cell sourcing to cryopreservation and GMP manufacturing. The Louisville facility includes apheresis suites, cleanrooms, and quality […]
Immorta Bio Inc. Announces Breakthrough in Liver Failure Treatment with Stem Cell Technology
Immorta Bio Inc., a company focused on longevity and regenerative medicine, has announced a significant breakthrough in the treatment of liver failure. The company is developing personalized stem cell technologies that show great promise in combating various diseases of aging. Immorta Bio’s research pipeline includes Personalized Regenerative Cells (PRCs), Personalized Mesenchymal Stem Cells (pMSCs), and […]
Theradaptive Secures Landmark Funding to Propel Human Clinical Trials in Stem Cell Research
In a groundbreaking development for stem cell research and regenerative medicine, Theradaptive has secured significant funding from the Maryland Stem Cell Research Fund (MSCRF). This crucial financial boost will support the advancement of their innovative human clinical trials, marking a significant milestone in the field of biotechnology. Theradaptive, a pioneering biopharmaceutical company, is renowned for […]
Revolutionizing Neurodegenerative Disease Treatment with Pluripotent Stem Cells: Insights from Sana Biotechnology
In an exciting development for the field of stem cell research, Sana Biotechnology has unveiled promising preclinical data in the prestigious journal, Nature Biotechnology. This data underscores the potential of pluripotent stem cell-derived human glial progenitor cells (hGPCs) in treating neurodegenerative diseases. Sana Biotechnology’s innovative approach focuses on harnessing the power of pluripotent stem cells, […]